Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults

Ítems similars

• Relative Bioavailabilities of Lisdexamfetamine Dimesylate and d-Amphetamine in Healthy Adults in an Open-Label, Randomized, Crossover Study After Mixing Lisdexamfetamine Dimesylate With Food or Drink
  per: Ermer, James, et al.
  Publicat: (2016)
• An Open-Label Investigation of the Pharmacokinetic Profiles of Lisdexamfetamine Dimesylate and Venlafaxine Extended-Release, Administered Alone and in Combination, in Healthy Adults
  per: Ermer, James, et al.
  Publicat: (2013)
• Pharmacokinetics of Coadministered Guanfacine Extended Release and Lisdexamfetamine Dimesylate
  per: Roesch, Benno, et al.
  Publicat: (2013)
• Lisdexamfetamine Dimesylate Effects on the Pharmacokinetics of Cytochrome P450 Substrates in Healthy Adults in an Open-Label, Randomized, Crossover Study
  per: Ermer, James, et al.
  Publicat: (2015)
• A phase 1, randomized, double‐blind, placebo‐controlled study to evaluate the safety, tolerability, and pharmacokinetics of single and multiple doses of lisdexamfetamine dimesylate in Japanese and Caucasian healthy adult subjects
  per: Ermer, James, et al.
  Publicat: (2019)